>
Both Sides Agree Iran Deal 'Close' But Not Finalized, As Trump Promises 'Final Determina
The Secret History of Biblical Giants, Demons, and the Advanced Civilizations Before the Great Flood
"Approaching Unheard Of Inventory Levels":
Cars Are Fast Becoming Dystopian Prison Pods...
Our Emergency Water Plan Wasn't Good Enough - So We Built This
Sodium Ion Batteries Can Reach 100 Gigawatt Per Hour Per Year Scale in 2027
Juiced Bikes proves capable electric motorcycles don't have to cost a lot
Headlight projectors turn your car into a drive-in theater
US To Develop Small Modular Nuclear Reactors For Commercial Shipping
New York Mandates Kill Switch and Surveillance Software in Your 3D Printer ...
Cameco Sees As Many As 20 AP1000 Nuclear Reactors On The Horizon
His grandparents had heart disease.
At 11, Laurent Simons decided he wanted to fight aging.
Mayo Clinic's AI Can Detect Pancreatic Cancer up to 3 Years Before Diagnosis–When Treatment...

We've actually been hearing a lot about "bioscaffolds" lately.
In a nutshell, they're three-dimensional pieces of biocompatible material that are implanted within the body, and that have a microstructure similar to that of the surrounding tissue. Over time, cells from that tissue migrate into the scaffold, colonizing it and reproducing. Eventually, they entirely replace the material, forming pure muscle, bone, cartilage or other tissue.
That said, pre-producing such bioscaffolds and then implanting them in muscle is quite challenging. With that in mind, scientists at the University of Connecticut developed a prototype handheld 3D printer to do the job.
It starts by depositing a gelatin-based hydrogel directly into the unwanted gap within the muscle. An integrated ultraviolet light causes that gel to cure into a bioscaffold made up of tiny muscle-like fibers, which readily adheres to the adjacent muscle tissue – no sutures are required. Muscle cells then move into the scaffolding.
In lab tests, the device proved to be effective at treating volumetric muscle loss injuries in mice.